I am a
Home I AM A Search Login

Papers of the Week


Papers: 11 Jun 2022 - 17 Jun 2022

PAIN TYPE:
Migraine/Headache


2022 Jun 13


BMC Neurol


22


1

OnabotulinumtoxinA in chronic migraine: is the response dose dependent?

Authors

Zandieh A, Cutrer F M
BMC Neurol. 2022 Jun 13; 22(1):218.
PMID: 35698027.

Abstract

OnabotulinumtoxinA has been widely used for control of chronic migraine. The aim of the current study was to evaluate the efficacy of different doses of the onabotulinumtoxinA therapy in patients with chronic migraine.